Dykstra: Amgen's Prospects Clear as Day

Mother Nature has pitched us myriad curveballs this winter season. We have seen mudslides and cherry blossoms in early January followed closely by whiteouts and ice storms in many parts of the country. One week we are playing an unexpected round of off-season golf, and the next we are housebound by frigid temperatures.

For the first time in eight years, the groundhog did not see his shadow, which only happens about 10% of the time, indicating a swift and imminent arrival of the spring months. This weekend, however, a winter storm crushed parts of the Midwest and Northeast.

Confused? I am.

But I am not confused about the fact that at Friday's close of $66.23, Amgen(AMGN Quote), the world's largest biotechnology company, is undervalued, to say the least. ...